Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.225 USD | +1.42% | +9.69% | +13.56% |
05-15 | Transcript : Aytu BioPharma, Inc., Q3 2024 Earnings Call, May 15, 2024 | |
05-15 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q3 Revenue $18M, vs. Street Est of $17.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.56% | 17.71M | |
+38.69% | 728B | |
+33.05% | 603B | |
-5.43% | 360B | |
+19.09% | 332B | |
+1.48% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.53% | 164B |
- Stock Market
- Equities
- AYTU Stock
- News Aytu BioPharma, Inc.
- Earnings Flash (AYTU) AYTU BIOPHARMA Posts Q2 Revenue $26.3M